World Health Organization site
Skip Navigation Links

Please fill this short user satisfaction survey


Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02128984
Date of registration: 28/03/2014
Prospective Registration: No
Primary sponsor: Laboratorios Ordesa
Public title: Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children VITJUNIOR
Scientific title: Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children
Date of first enrolment: January 2012
Target sample size: 109
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02128984
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Peru Spain
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Malnutrition (P / T <-1 SD) by intake deficit without organic disease (failure to
thrive) and / or patients diagnosed with Cystic Fibrosis).

- Age >= 1 year.

- Stable patients

- No antibiotherapy in the last 30 days

- Inform consent signed (parent/legal representative)

Exclusion Criteria:

- Patients with allergy / intolerance to cow's milk proteins

- Metabolically unstable patient

- Patients with metabolic intolerance to carbohydrates

- Patients with severe disease in the last 30 days



Age minimum: 1 Year
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Failure to Thrive
Malnutrition
Cystic Fibrosis
Intervention(s)
Dietary Supplement: Standard Formula
Dietary Supplement: Symbiotic Formula with DHA and antioxidants
Primary Outcome(s)
Changes in inflammatory response [Time Frame: At 3rd and 6th months]
Secondary Outcome(s)
Incidence of Infections [Time Frame: At 1st, 3rd and 6th months]
Changes in nutritional status [Time Frame: At 3rd and 6th months]
Changes in Interleukin levels [Time Frame: At 6th month]
Changes in microbiota profile [Time Frame: At 3rd and 6th months]
Secondary ID(s)
VIT-2572-011
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Quantum Experimental
Peruvian Clinical Research
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history Please fill this short user satisfaction survey